References
- Facts about rosacea. Accessed: November 8, 2007. URL: http://www.niams.nih.gov/Health_Info/Rosacea/default.asp
- Jansen T., Plewig G. Rosacea: Classification and treatment. J R Soc Med 1997; 90: 144–50
- Kligman A. M. A personal critique on the state of knowledge of rosacea. Dermatology 2004; 208: 191–7
- Crawford G. H., Pelle M. T., James W. D. Rosacea, I: Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51: 327–41
- Willkin J., Dahl M., Detmar M., Drake L., Feinstein A., Odom R., et al. Standard classification of rosacea: Report of the National Rosacea Society expert committee on the classification and staging of rosacea. J Am Acad Dermatol 2002; 46: 584–7
- Willkin J., Dahl M., Detmar M., Drake L., Feinstein A., Odom R., et al. Standard grading system for rosacea: Report of the National Rosacea Society expert committee on the classification and staging of rosacea. J Am Acad Dermatol 2004; 50: 907–12
- Michel J. L., Cabibel F. Frequency, severity and treatment of ocular rosacea during cutaneous rosacea [French]. Ann Dermatol Venereol 2003; 130: 20–4
- National Rosacea Society. Accessed: November 8, 2007. URL: http://www.rosacea.org/index.php
- Del Rosso J. Q. Medical treatment of rosacea with emphasis on topical therapies. Expert Opin Pharmacother 2004; 5: 5–13
- Nally J. B., Berson D. S. Topical therapies for rosacea. J Drugs Dermatol 2006; 5: 23–6
- Zuber T. J. Rosacea. Prim Care 2000; 27: 309–18
- Akamatsu H., Oguchi M., Nishijima S., Asada Y., Takahashi M., Ushijima T., et al. The inhibition of free radical generation by human neutrophils through the synergistic effects of metronidazole with palmitoleic acid: A possible mechanism of action of metronidazole in rosacea and acne. Arch Dermatol Res 1990; 282: 449–54
- Gnarpe H., Belsheim J., Persson S. Influence of nitroimidazole derivatives on leukocyte migration. Scand J Infect Dis Suppl 1981; 26: 68–71
- Persi A., Rebora A. Metronidazole and Demodex folliculorum. Acta Derm Venereol 1981; 61: 182–3
- Wolf J. E Jr. The role of topical metronidazole in the treatment of rosacea. Cutis 2004; 73((suppl I):)19–28
- Van Zuuren E., Graber M. A., Hollis S., Chaudhry M., Gupta A. K. Interventions for rosacea. Cochrane Database Syst Rev 2004; 1: CD003262
- Del Rosso J. Q. A status report on medical management of rosacea: Focus on topical therapies. Cutis 2002; 70: 271–5
- Pelle M. T., Crawford G. H., James W. D. Rosacea: II. Therapy. J Am Acad Dermatol 2004; 51: 499–512
- Caroll C. L., Feldman S. R., Camacho F. T., Manuel J. C., Balkrishnan R. Adherence to topical therapy decreases during the course of an 8‐week psoriasis clinical trial: Commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 2004; 51: 212–16
- Bender B. G., Rand C. Medication non‐adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol 2004; 4: 191–5
- Berg J. S., Dischler J., Wagner D. J., Raia J. J., Palmer‐Shevlin N. Medication compliance: A healthcare problem. Ann Pharmacother 1993; 27: S1–24
- Stein K. R., Pearce D. J., Feldman S. R. The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis care. Semin Cutan Med Surg 2005; 24: 512–57
- Wolf J. E, Jr. Medication adherence: A key factor in effective management of rosacea. Adv Ther 2001; 18: 272–81
- Centers for Medicare and Medicaid services; Table of contents for the state of NC. Accessed: November 1, 2007. URL: http://www.cms.hss.gov/medicaid/stateplans/toc.asp?state =
- Halvorsen R., Palmquist R. The interpretation of dummy variables in semilogarithmic equations. Am Econ Rev 1980; 70: 474–5
- Kennedy P. Estimation with correctly interpreted dummy variables in semilogarithmic equations. Am Econ Rev 1981; 71: 801
- Habif T. P. Clinical dermatology: A color guide to diagnosis and therapy. Mosby, St Louis 1996; 182–3
- Blount W. B., Pelletier A. L. Rosacea: A common, yet overlooked condition. Am Fam Physician 2002; 66: 435–40
- Willkin J. K. Rosacea: Pathophysiology and treatment [Editorial]. Arch Dermatol 1999; 130: 359–62